I20 I20.1 I20.8 I20.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: women between 18-85 years old who have clinical symptoms of stabile angina pectoris (stenocardia or dyspnea in physical exertion) and are able to understand and sign informed consent.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. Patients with symptoms of unstable angina pectoris (stenocardia or chest pain/pressure at rest or in minimal physical activity 2. Patients with known coronary artery disease with or without implantated coronary stents 3. Patients with suffered myocardial infarction (STEMI, NSTEMI), 4. Patients with left bundle branch block, 5. Patients with implantated perenent cardiac pacemaker or ICD, 6. Patients that underwent the cardiothoracic myocardial revascularisation with coronary artery by-pass graft (CABG) and/or replacement of one or more cardiac valves 7. Patients with congenital cardiac anomaly (corrected or not) 8. Patients with dysfunction of one or more cardiac valves of moderate to severe stage, or left ventricular aneurysm (all proved with echocardiography) 9. Patients with chronic renal insufficiency of = III stage 10. Pregnant women 11. Patients with chronic obstructive pulmonary disease (COPD) 12. Patients with life-expectance less than 12 months 13. Patients with anaemia (haemoglobin < 100 g/L) 14. Patients with history of alcohol and/or drug abuse 15. Patients who are involved in another clinical trial 16. Patients who are, regarding their behaviour, not expected to accomplish this trial (compliance, impossibility for coronarography to be done in our center) 17. Patients with emergency clinical status during the hospitalization (no matter the cause) 18. Patients with no signed informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficiency (sensitivity and specificity) of cardiogoniometry in diagnostics of coronary artery disease (CAD) in women with stabile angina pectoris In every woman with clinical symptoms of angina pectoris and suspected CAD, undergoing coronary angiography, the cardiogoniometry will be done. The coronary angiography is the invasive method for determining the presence of significant CAD. The results of cardiogoniometry, which is a non-invasive diagnostic method, will be compared with results of coronary angiographies in every individual female patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of cardiogoniometry’s efficiency with the one of ergometry, in detecting CAD in women with clinical angina pectoris | — |
Countries
Croatia
Contacts
University Hospital Centre Sisters of Charity, Zagreb, Croatia